Keywords: ph, ii, data, coulter, bexxar, phase, trial

Ph II Data With Coulter's Bexxar

Article | 11 December 1997

Print This

- Data from a Phase II trial of Coulter Pharmaceutical's Bexxar, anantibody conjugated to radiolabeled iodine, have shown an overall response ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in